/Investor DB

Genoa Ventures — Full Portfolio

32 tracked investments · listed companies and verified rows first

BrightSpecbrightspec.cominSeries C · May 2025 · $18M

BrightSpec develops molecular rotational resonance (MRR) spectroscopy instruments and software that identify and quantify gas-phase molecules from complex mixtures without front-end separation.

BiotechDeep TechHardwareWaltham, US

Rick Gordon(CEO)inWalter Colsman(Executive Officer, Director)JAFFRAY WOODRIFF(Director)ROBERT LLOYD(Executive Officer, Director)THOMAS JONES(Director)DAVID MCDANIEL(Executive Officer, Director)

Board seatJenny Rooke· per SEC Form D

Co-investorsArboretum VenturesMedvest Capital

Intabiointabio.comJun 2017

BiotechPortola Valley, US

Lena Wu(Executive Officer, Director)Erik Gentalen(Director)Michael Rubin(Director)

Board seatJenny Rooke· per SEC Form D

Co-investorsHemisphere Ventures LLCVertical Venture PartnersNorthpond Ventures

Alida Bioalidabio.comin

Alida Biosciences develops tools for RNA modification detection and analysis that enable research and diagnostic applications across drug discovery, clinical testing, and biotechnology.

AI & Machine LearningBiotechData & InfrastructureDeep TechHealthtechSan Diego, US

Byron Purse(Co-Founder)inJohn Drewry(Director)inGudrun Stengel(CEO & Co-Founder)

Co-investorsFusionX VenturesGENERAL INCEPTIONVertical Venture PartnersPaladin Capital Group

Aqtualaqtual.comin

Aqtual is a precision medicine company led by experienced healthcare professionals, entrepreneurs, and technical experts.

AI & Machine LearningHealthtechMedical DevicesHayward, US

Diana Abdueva(Founder)inRichard Rava(Founder)

Co-investorsBold Capital PartnersBOLD LongevityManta Ray Ventures

Attune Neurosciencesattuneneuro.comin

Attune develops a wearable platform that delivers targeted, adaptive focused-ultrasound neuromodulation to the deep brain to affect mood, focus, and performance.

Deep TechMedical DevicesWellness & Fitness

Rajiv Mahadevan(Founder)inKeith Murphy(Co-Founder & CTO)in

Co-investorsJoyance PartnersStartX

Bond Pet FoodsinSeries A · Jun 2022 · $18M

Produces real meat proteins from precision fermentation as ingredients for the pet food sector.

Boulder, US

Rich Kelleman(Executive Officer, Director)in

BoardNick Cooney(Director)inTony Day(Director)inDave Summa(Director)

Co-investorsAgronomicsArgonautic VenturesCavallo VenturesiSelect FundLever VCTrellis Road I Fund AB+1 more

Bondpetsbondpets.comin𝕏

Bond Pets develops brewed meat proteins using precision fermentation for pet food products that are marketed as better for pets, farm animals, and the planet.

BiotechFoodTechBoulder, US

Rich Kelleman(Founder)in

Co-investorsAgronomicsCavallo VenturesiSelect FundLever VC

Brainbox Solutionsbrainboxinc.cominSeries A · Oct 2023 · $23M

BRAINBox Solutions develops a multi-modality diagnostic approach for mild traumatic brain injury (mTBI), combining blood biomarker panels with tablet-based neurocognitive testing to produce an objective injury score and a prognosis of post-injury symptoms.

AI & Machine LearningBiotechDigital HealthMedical DevicesHouston, US

Steve Wallace(Chief Operating Officer, Global Supply Chain Management)inDonna J. Edmonds(CEO)inJames V. Snider(Chief Technology Officer / Advisor)Tim Van Meter(Chief Scientific Officer)Richard Noel(Chief Product and Commercial Officer)inRobert Sledd(Director)

Co-investorsAmbit Health VenturesBioventures InvestorsVTC VenturesGENERAL INCEPTION

Codetta Biocodettabio.com

Codetta Bio develops multiplex biomarker detection technology that combines digital PCR, real-time PCR, and immunoPCR with microbead-based target capture to simultaneously measure proteins, DNA, and RNA from a single sample.

BiotechDeep TechHardwareMorrisville, US

Michael Ramsey(Co-Founder)Jacques Corriveau(Executive Officer, Director)inWilliam Hampton Henley(Executive Officer)J. Michael Ramsey(Director)in

BoardJohn Ho(Director)in

Co-investorsAnzu PartnersBantam Group

Curegetcure.appinMay 2026

CURE operates a booking platform that connects pharmacies with delivery service partners to generate online orders.

B2B MarketplacesHealthtechSaaSBerlin, DE

Manuel Aberle(Founder)in

Co-investorsAbstract VenturesArtis VenturesFJ LabsJ12 VenturesStella CapitalAccel+23 more

Epitelepitel.comSeries A · Feb 2022 · $12.5M

Epitel is a digital health company that builds REMI, a wearable, wireless cloud-based EEG monitoring system with AI-based seizure event detection for use in healthcare and ambulatory settings.

AI & Machine LearningDigital HealthHealthtechMedical DevicesSalt Lake City, US

Mark Lehmkuhle(CTO, Founder)inSteve Pacelli(CEO)in

Co-investorsAngel Physicians FundCatalyst Health VenturesIdeashipMedMountain VenturesOSF VenturesStar51 Capital+1 more

Extracellularextracellular.cominNov 2025

Extracellular is a biomanufacturing company that helps cell-based product developers in cultivated meat, plant cell culture, and bioactives accelerate discovery, overcome production challenges, and commercialize their products.

Advanced ManufacturingBiotechFoodTechNew Materials

Will Milligan(CEO & Founder)in

Co-investorsBig Idea VenturesFFFNewland SyndicateUnruly Capital5AM VenturesAgent Capital+8 more

Fellowmeetfellow.comin𝕏

Fellow operates a CLIA-certified diagnostics lab offering mail-in semen analysis for vasectomy and fertility testing, delivering clinically valid results without an in-person lab visit.

Digital HealthHealthtechMedical Devices

Co-investorsGreat Oaks Venture CapitalHuman CapitalJovonoMantis CapitalMyelin VCOverwater Ventures Llc+5 more

GENERAL INCEPTIONgeneralinception.comSep 2022

General Inception is an operational support and company building firm that handles day-to-day planning and execution for building companies, with a focus on life science tools and diagnostics.

Deep TechHealthtechMedical Devices

Co-investorsOMX VenturesPaladin Capital GroupNorthpond VenturesVertical Venture Partners

Hermes Bioscienceshermesbio.comin

Hermes Biosciences develops a benchtop system for isolating extracellular vesicles and exosomes from bodily fluids and cell culture media for research and clinical applications in oncology, degenerative disease, and regenerative medicine.

BiotechDeep TechMedical Devices

Hermes Bioscienceshermesbiosciences.cominSeed · Nov 2025 · $6M

Hermes Biosciences develops a benchtop extracellular vesicle isolation system that purifies exosomes from bodily fluids and cell culture media for research and clinical applications in oncology, degenerative disease, and regenerative medicine.

BiotechDeep TechMedical Devices

Co-investorsGENERAL INCEPTIONPaladin Capital Group

HydRegenhydregenoxford.comin𝕏Sep 2026

Hydregen develops biocatalysis platform technologies that integrate into existing chemical manufacturing infrastructure, aiming to cut process costs by 40-50% while lowering energy use and carbon emissions.

BiotechCleantechNew MaterialsThame, GB

William Barton(Promoter)Kylie Vincent(Promoter)Holly Reeve(Executive Officer, Director)inMatthew Hodges(Executive Officer)inJose De Sousa(Director)Kevin Matthews(Director)in

Co-investorsClean Growth FundFirst Imagine!Future Planet CapitalOxford Investment Opportunity Network (OION)Oxford Technology ManagementUK Innovation & Science Seed Fund

InterVenn Biosciencesintervenn.comDec 2018 · $9M

InterVenn applies glycoproteomics combined with artificial intelligence to study women's health conditions such as ovarian cancer and endometriosis, mapping glycoprotein control points linked to disease progression.

AI & Machine LearningBiotechFemTech

Aldo Carrascoso(Founder)Carlito Lebrilla(Founder)inCarolyn Bertozzi(Founder)

Co-investorsAmplify PartnersAnzu PartnersSoftBank Vision FundXeraya CapitalTrue Ventures

Meiogenixmeiogenix.cominSeries A · Dec 2021 · $12M

Meiogenix develops a proprietary recombination technology that targets meiotic recombination to accelerate genetic gain and variety development in crops.

AgTechBiotechDeep Tech

Ricardo Garcia de Albain

Co-investorsKurma PartnersSofinnova PartnersCasdin Capital

New Culturenewculture.comin𝕏Nov 2021

New Culture produces animal-free dairy cheese products, starting with mozzarella for pizzerias, using food science to replicate the taste, melt, and stretch of conventional cheese.

Climate TechFoodTechSan Leandro, US

Matthew Gibson(Executive Officer, Director)inInja Radman(Founder)inMatt Gibson(Founder)inMatt Gibson Inja Radman(Founder)

BoardSteve Sanger(Director)

Co-investorsAhren Innovation CapitalAsymmetry VenturesBee PartnersBluestein VenturesS2G InvestmentsSynthesis Capital+2 more

Reduxbioreduxbio.com

Redux Bio develops bio-based vaccines and biological solutions for animal health and aquaculture, including fish and other livestock products.

AgTechBiotechHealthtech

Lincoln Tubbs(CEO)Richard Kenny(VP Finance)inTony Day(VP R&D)in

BoardMiguel Angelo De Facci de Oliveira(Active Director)Aaron Schacht(Active Director)in

Sciexsciex.comin𝕏

SCIEX develops mass spectrometry and capillary electrophoresis instruments, along with software and integrated workflows, for the precision detection and quantitation of molecules.

BiotechHardwareMedical Devices

Simbiosyssimbiosys.comin𝕏Series A · Oct 2021 · $15M

SimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning.

AI & Machine LearningBiotechDigital HealthMedical DevicesChicago, US

Joe Peterson(Co-founder)John Cole(Co-founder)Tushar Pandey(Co-founder)inStacey Stevens(Executive Officer, Director)in

BoardVikram Chaudhery(Director)inLucy Coassin(Director)

Co-investorsAV8 VenturesKleinmuntz AssociatesXcellerant VenturesGENERAL INCEPTIONNorthpond Ventures

Tropictropicapp.ioin

Tropic is a procurement platform that gives finance and procurement teams pricing intelligence, negotiation playbooks, and expert support to reduce spend on SaaS and AI software.

AI & Machine LearningFintechSaaSNew York City, US

Justin Etkin(Founder)inDavid Campbell(Founder)in

Co-investorsCanaan PartnersFOG VenturesFounder CollectiveInsight PartnersShine CapitalForbion

Tropic Biosciencestropic.bioinSeries B · Jun 2020 · $29M

Tropic develops improved varieties of tropical crops using gene editing and gene silencing technologies to enhance yield, disease resistance, and climate resilience.

AgTechBiotechFoodTechNorwich, GB

Co-investorsAgronomicsAliment CapitalAutochrome VenturesBloom8Blue Horizon CorporationCanaan Partners+9 more

Zenlnkd.in

HealthtechWellness & FitnessNew York City, US

Daniel James(Founder)Ion-Alexandru Secara

Co-investorsBowery CapitalFocal VenturesFYNSA Private CapitalHelicapHitachi VenturesOnsight Ventures+8 more

ZwitterCozwitterco.comin

ZwitterCo develops zwitterionic anti-fouling membranes that resist organic fouling for filtration of industrial wastewater and process streams.

Advanced ManufacturingCleantechNew MaterialsCambridge, US

Alex Rappaport(Co-Founder & CEO)in

BoardStephen Remondi(Director)

Co-investorsBantam GroupBURNT ISLAND VENTURESDCVC (Data Collective)HG VenturesWhite Shark VenturesEvok Innovations+1 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

FCRE Arabella, LLCFCRE SOTO, LLCVenn BiosciencesAdarza BioSystemsSynthomics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.